By growing human tumors in mice, NIBR develops a unique system that seeks to mimic clinical trials of cancer drugs

New Global Head of Business Development and Licensing for research makes connections naturally, decisions scientifically.

NIBR investigator develops technology that uses tumor DNA in the blood for diagnostics

Bioengineers, immunologists and clinicians collaborate to explore a new approach to fighting cancer.

The recently appointed leader of the Novartis’ digital research and development platform data42 is a strong believer that data and digital technologies will change the path of medical science.